Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review

BACKGROUND: Novel tuberculosis (TB) drugs and the need to treat drug-resistant tuberculosis (DR-TB) are likely to bring about substantial transformations in TB treatment in coming years. An evidence base for cost and cost-effectiveness analyses of these developments is needed. OBJECTIVE: Our objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurence, Yoko V., Griffiths, Ulla K., Vassall, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559093/
https://www.ncbi.nlm.nih.gov/pubmed/25939501
http://dx.doi.org/10.1007/s40273-015-0279-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559093/
https://www.ncbi.nlm.nih.gov/pubmed/25939501
http://dx.doi.org/10.1007/s40273-015-0279-6

Ejemplares similares